A Reactive Prodrug Ink Formulation Strategy for Inkjet 3D Printing of Controlled Release Dosage Forms and Implants
- Submitting institution
-
University of Nottingham, The
- Unit of assessment
- 12 - Engineering
- Output identifier
- 3933280
- Type
- D - Journal article
- DOI
-
10.1002/adtp.201900187
- Title of journal
- Advanced Therapeutics
- Article number
- 1900187
- First page
- -
- Volume
- 3
- Issue
- 6
- ISSN
- 2366-3987
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
13
- Research group(s)
-
F - Centre for Additive Manufacturing (CfAM)
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This collaborative paper between the School of Pharmacy and Faculty of Engineering highlights a new approach to incorporating drugs into implants that can enable high dose and refined control. These formulations are suitable for 3D printing and have potential to overcome significant issues that currently prevent adoption of such technologies in the pharmaceuticals sector for the production of tailored drug delivery devices. The work was supported by EPSRC (EP/I033335/2, EP/N024818/1, and EP/P031684/1).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
